Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;5(9):e2232679.
doi: 10.1001/jamanetworkopen.2022.32679.

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France

Adeline Paumier  1 , Antoine Asquier-Khati  1   2 , Sonia Thibaut  3 , Thomas Coeffic  3 , Olivier Lemenand  3 , Stéphanie Larramendy  2 , Brice Leclère  4 , Jocelyne Caillon  3 , David Boutoille  5 , Gabriel Birgand  1   3   6 ; French Clinical Laboratories Nationwide Network
Collaborators, Affiliations

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France

Adeline Paumier et al. JAMA Netw Open. .

Abstract

Importance: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is considered a leading pathogen contributing to the global burden of antimicrobial resistance.

Objective: To better understand factors associated with the heterogeneity of community-acquired ESBL-producing E coli urinary tract infections (UTIs) in France.

Design, setting, and participants: This cross-sectional study performed from January 1 to December 31, 2021, was based on data collected via PRIMO (Surveillance and Prevention of Antimicrobial Resistance in Primary Care and Nursing Homes), a nationwide clinical laboratory surveillance system in France. Strains of E coli isolated from community urine samples from January 1 to December 31, 2019, from 59 administrative departments of metropolitan France were included.

Main outcomes and measures: Quasi-Poisson regression models were used to assess the associations between several ecological factors available on government and administration websites between 2010 and 2020 (demographic population structure, living conditions, baseline health care services, antibiotic consumptions, economic indicators, animal farming density, and environmental characteristics) and the number of ESBL-producing E coli strains isolated from urine samples of individuals with community-acquired UTI in 2019.

Results: Among 444 281 E coli isolates from urine samples tested in 1013 laboratories, the mean prevalence of ESBL-producing E coli was 3.0% (range, 1.4%-8.8%). In an adjusted model, the number of community-acquired ESBL-producing E coli UTIs in each department was positively associated with the percentage of children younger than 5 years (adjusted β1 coefficient, 0.112 [95% CI, 0.040-0.185]; P = .004), overcrowded households (adjusted β1 coefficient, 0.049 [95% CI, 0.034 to 0.062]; P < .001), consumption of fluoroquinolones (adjusted β1 coefficient, 0.002 [95% CI, 0.001-0.002]; P < .001), and tetracyclines (adjusted β1 coefficient, 0.0002 [0.00004 to 0.00039]; P = .02), and poultry density (adjusted β1 coefficient, 0.0001 [95% CI, 0.0001-0.0002]; P < .001). The social deprivation index (adjusted β1 coefficient, -0.115 [95% CI, -0.165 to -0.064]; P < .001) and the proportion of water surface area (adjusted β1 coefficient, -0.052 [-0.081 to -0.024]; P = .001) were negatively associated with a higher number of community-acquired ESBL-producing E coli UTIs.

Conclusions and relevance: The findings of this cross-sectional study suggest that multiple human health, animal health, and environmental factors are associated with the occurence of community-acquired ESBL E coli UTI. Strategies to mitigate ESBL in the community should follow the One Health approach and address the role played by fluoroquinolones, tetracycline use, poultry density, overcrowded households, and preschool-aged children.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Birgand reported receiving grants from Santé Publique France during the conduct of the study. No other disclosures were reported.

Figures

Figure.
Figure.. Extended-Spectrum β-Lactamase (ESBL)–Producing Escherichia coli Isolates From Urine Samples of Individuals With Community-Acquired Urinary Tract Infections
Data are from January 1 to December 31, 2019, by French departments. NA indicates not available.
See this image and copyright information in PMC

References

    1. Kaye KS, Gupta V, Mulgirigama A, et al. . Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rising ESBL strains and impact on patient management. Clin Infect Dis. 2021;73(11):1992-1999. doi:10.1093/cid/ciab560 - DOI - PMC - PubMed
    1. Larramendy S, Gaultier A, Fournier JP, Caillon J, Moret L, Beaudeau F. Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study. J Antimicrob Chemother. 2021;76(3):789-795. doi:10.1093/jac/dkaa514 - DOI - PubMed
    1. Sardá V, Trick WE, Zhang H, Schwartz DN. Spatial, ecologic, and clinical epidemiology of community-onset, ceftriaxone-resistant Enterobacteriaceae, Cook County, Illinois, USA. Emerg Infect Dis. 2021;27(8):2127-2134. doi:10.3201/eid2708.204235 - DOI - PMC - PubMed
    1. Larramendy S, Deglaire V, Dusollier P, et al. . Risk factors of extended-spectrum beta-lactamases-producing Escherichia coli community-acquired urinary tract infections: a systematic review. Infect Drug Resist. 2020;13:3945-3955. doi:10.2147/IDR.S269033 - DOI - PMC - PubMed
    1. Nomamiukor BO, Horner C, Kirby A, Hughes GJ. Living conditions are associated with increased antibiotic resistance in community isolates of Escherichia coli. J Antimicrob Chemother. 2015;70(11):3154-3158. doi:10.1093/jac/dkv229 - DOI - PubMed

Publication types

MeSH terms